Skip to content

Evolent Health, Inc. EVH Restricted Cash and Investments

Restricted Cash and Investments at other companies

Republic Services logo
Republic ServicesRSG
$292M+31.5%
Freeport-McMoRan Inc. logo
Freeport-McMoRan Inc.FCX
$280M-39.1%
Achieve Life Sciences logo
Achieve Life SciencesACHV
$52K+33.3%
NNN REIT logo
NNN REITNNN
$827K+93.7%
UDR logo
UDRUDR
$33.5M+4.4%
Rayonier logo
RayonierRYN
$495K-26.9%

Other financials

Income statement

See full
Revenue$496.2M+2.6%
Gross profit$83.8M-18.2%
Operating income-$10.6M-553%
Net income-$26.6M+58.8%
EPS (diluted)-$0.24+61.9%

Balance sheet

See full
Cash & equivalents$142.0M-42.4%
Total debt$985.4M+13.3%
Total equity$396.4M-57.6%
Total assets$1.9B-29.2%

Cash flow

See full
Operating cash flow-$984.0K-122%

Valuation

See full
Market cap$565.78M-47.9%
Enterprise value$1.41B-17.6%
P/S0.3×-0.2×

Profitability

See full
Gross margin20.2%+4.9pp
Operating margin-22.2%-23.5pp
Net margin-26.3%-33.2pp
FCF margin-9.7%

Returns & leverage

See full
Return on equity-74.6%-90.1pp
Debt / equity2.5×+1.6×
Current ratio1.3×+0.3×

Where this comes from

Reported directly by Evolent Health, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RestrictedCashAndInvestmentsNoncurrent.

The official record: Evolent Health, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evolent Health, Inc.'s restricted cash and investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Evolent Health, Inc.'s restricted cash and investments?
Evolent Health, Inc. (EVH) reported restricted cash and investments of $2.74M in Q1 2026.
How has Evolent Health, Inc.'s restricted cash and investments changed year-over-year?
Evolent Health, Inc.'s restricted cash and investments decreased by 81.8% year-over-year, from $15.06M to $2.74M.
What is the long-term trend for Evolent Health, Inc.'s restricted cash and investments?
Over 5 years (2020 to 2025), Evolent Health, Inc.'s restricted cash and investments has grown at a -16.5% compound annual growth rate (CAGR), from $6.65M to $2.71M.